Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Henning, Reis"'
Autor:
Yuri Tolkach, Vlado Ovtcharov, Alexey Pryalukhin, Marie-Lisa Eich, Nadine Therese Gaisa, Martin Braun, Abdukhamid Radzhabov, Alexander Quaas, Peter Hammerer, Ansgar Dellmann, Wolfgang Hulla, Michael C. Haffner, Henning Reis, Ibrahim Fahoum, Iryna Samarska, Artem Borbat, Hoa Pham, Axel Heidenreich, Sebastian Klein, George Netto, Peter Caie, Reinhard Buettner
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-9 (2023)
Abstract Pathologic examination of prostate biopsies is time consuming due to the large number of slides per case. In this retrospective study, we validate a deep learning-based classifier for prostate cancer (PCA) detection and Gleason grading (AI t
Externí odkaz:
https://doaj.org/article/21c0c2f5c021418b81a6adbfc9cf02b8
Autor:
Christopher Darr, Pedro Fragoso Costa, Theresa Kahl, Alexandros Moraitis, Jenna Engel, Mulham Al-Nader, Henning Reis, Jens Köllermann, Claudia Kesch, Ulrich Krafft, Tobias Maurer, Daniel Köhler, Susanne Klutmann, Fabian Falkenbach, Jens Kleesiek, Wolfgang P. Fendler, Boris A. Hadaschik, Ken Herrmann
Publikováno v:
European Urology Open Science, Vol 54, Iss , Pp 28-32 (2023)
In this prospective two-center feasibility study, we evaluate the diagnostic value of intraoperative ex vivo specimenPET/CT imaging of radical prostatectomy (RP) and lymphadenectomy specimens. Ten patients with high-risk prostate cancer underwent cli
Externí odkaz:
https://doaj.org/article/8a126cb7bf0b4692a6caa9dd993de240
Autor:
Florestan J. Koll, Claudia Döring, Csilla Olah, Tibor Szarvas, Jens Köllermann, Benedikt Hoeh, Felix K.-H. Chun, Henning Reis, Peter J. Wild
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Molecular subtypes predict prognosis in muscle-invasive bladder cancer (MIBC) and are explored as predictive markers. To provide a common base for molecular subtyping and facilitate clinical applications, a consensus classificatio
Externí odkaz:
https://doaj.org/article/be9abe9cb2c64dd1a0fe2694296bfac9
Autor:
Melinda Varadi, Nikolett Nagy, Henning Reis, Boris Hadaschik, Christian Niedworok, Orsolya Modos, Attila Szendroi, Jason Ablat, Peter C. Black, David Keresztes, Anita Csizmarik, Csilla Olah, Nadine T. Gaisa, Andras Kiss, Jozsef Timar, Erika Toth, Erzsebet Csernak, Arpad Gerstner, Vinay Mittal, Sofia Karkampouna, Marianna Kruithof de Julio, Balazs Gyorffy, Gabor Bedics, Michael Rink, Margit Fisch, Peter Nyirady, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 9041-9054 (2023)
Abstract Objective Administration of targeted therapies provides a promising treatment strategy for urachal adenocarcinoma (UrC) or primary bladder adenocarcinoma (PBAC); however, the selection of appropriate drugs remains difficult. Here, we aimed t
Externí odkaz:
https://doaj.org/article/e41fec3667254bd390a37fade443482d
Autor:
Maximilian N. Kinzler, Katrin Bankov, Julia Bein, Claudia Döring, Falko Schulze, Henning Reis, Scherwin Mahmoudi, Vitali Koch, Leon D. Grünewald, Angelika Stehle, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Peter J. Wild, Thomas J. Vogl, Simon Bernatz
Publikováno v:
Current Oncology, Vol 30, Iss 3, Pp 3516-3528 (2023)
Distinct immune patterns of hepatocellular carcinoma (HCC) may have prognostic implications in the response to transarterial chemoembolization (TACE). Thus, we aimed to exploratively analyze tumor tissue of HCC patients who do or do not respond to TA
Externí odkaz:
https://doaj.org/article/87d021d14c2c44dda2af6250382a0a39
Autor:
Csilla Olah, Henning Reis, Michèle J. Hoffmann, Fabian Mairinger, Saskia Ting, Boris Hadaschik, Ulrich Krafft, Viktor Grünwald, Peter Nyirady, Melinda Varadi, Balázs Győrffy, Andras Kiss, Eszter Szekely, Gottfrid Sjödahl, Tibor Szarvas
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5222-5232 (2023)
Abstract Objective Although targeted approaches have become available in second‐ and third‐line settings, platinum‐based chemotherapy remains the standard first‐line treatment for advanced muscle‐invasive bladder cancer (MIBC). Therefore, t
Externí odkaz:
https://doaj.org/article/7547c69a833c47a98b4d560264ca3735
Autor:
Florestan J. Koll, Severine Banek, Luis Kluth, Jens Köllermann, Katrin Bankov, Felix K.-H. Chun, Peter J. Wild, Andreas Weigert, Henning Reis
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Introduction and objective Muscle-invasive urothelial bladder cancer (MIBC) is associated with limited response rates to systemic therapy, risk of recurrence and death. Tumor infiltrating immune cells have been associated with outcome and re
Externí odkaz:
https://doaj.org/article/da0b270fc410471db493b2359ea9d995
Autor:
Simon Bernatz, Oleg Elenberger, Jörg Ackermann, Lukas Lenga, Simon S. Martin, Jan-Erik Scholtz, Vitali Koch, Leon D. Grünewald, Yannis Herrmann, Maximilian N. Kinzler, Angelika Stehle, Ina Koch, Stefan Zeuzem, Katrin Bankov, Claudia Doering, Henning Reis, Nadine Flinner, Falko Schulze, Peter J. Wild, Renate Hammerstingl, Katrin Eichler, Tatjana Gruber-Rouh, Thomas J. Vogl, Daniel Pinto dos Santos, Scherwin Mahmoudi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract We aimed to identify hepatocellular carcinoma (HCC) patients who will respond to repetitive transarterial chemoembolization (TACE) to improve the treatment algorithm. Retrospectively, 61 patients (mean age, 65.3 years ± 10.0 [SD]; 49 men) w
Externí odkaz:
https://doaj.org/article/93254461f6d9412381cfcac4e1c1af0e
Autor:
Yauheniya Zhdanovich, Jörg Ackermann, Peter J. Wild, Jens Köllermann, Katrin Bankov, Claudia Döring, Nadine Flinner, Henning Reis, Mike Wenzel, Benedikt Höh, Philipp Mandel, Thomas J. Vogl, Patrick Harter, Katharina Filipski, Ina Koch, Simon Bernatz
Publikováno v:
BMC Bioinformatics, Vol 24, Iss 1, Pp 1-14 (2023)
Abstract Background Prostate cancer is a major health concern in aging men. Paralleling an aging society, prostate cancer prevalence increases emphasizing the need for efficient diagnostic algorithms. Methods Retrospectively, 106 prostate tissue samp
Externí odkaz:
https://doaj.org/article/532f11674417410a85d48b26aa59cb1d
Autor:
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, Marcel Wiesweg, Sabrina Borchert, Elena Mairinger, Jens Kollmeier, Henning Reis, Torsten Bauer, Kurt Werner Schmid, Thomas Mairinger, Martin Schuler, Fabian D. Mairinger
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Immune checkpoint inhibitors (ICIs) are currently one of the most promising therapy options in the field of oncology. Although the first pivotal ICI trial results were published in 2011, few biomarkers exist to predict their thera
Externí odkaz:
https://doaj.org/article/ba9aee6c71794d6f8106a205ed38e4c9